Crescent Capital BDC Inc
(NASDAQ:CCAP)
The dividend Ex-Date is today
$16.685
-0.005[-0.03%]
Last update: 11:11AM (Delayed 15-Minutes)
Get Real Time Here
$16.69
0.0050[0.03%]
After-Hours
Open16.690Close-
Vol / Avg.18.801K / 103.824KMkt Cap618.372M
Day Range16.630 - 16.80052 Wk Range12.560 - 17.550

Crescent Capital BDC Stock (NASDAQ:CCAP), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Outperform

Highest Price Target1

$19.50

Lowest Price Target1

$16.00

Consensus Price Target1

$14.92

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
40000

Analyst Firms Making Recommendations1

  • Wells Fargo
  • Oppenheimer
  • Keefe, Bruyette & Woods
  • Raymond James
  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Crescent Capital BDC

Upgrades (1)

Downgrades (1)

Initiations (3)

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
11/13/2023CCAPBuy Now
Crescent Capital BDC
$16.68-4.11%Wells Fargo
Finian O'Shea
$16.5 → $16DowngradeOverweight → Equal-WeightGet Alert
05/16/2023CCAPBuy Now
Crescent Capital BDC
$16.687.88%Oppenheimer
Mitchel Penn
→ $18ReiteratesOutperform → OutperformGet Alert
04/11/2023CCAPBuy Now
Crescent Capital BDC
$16.687.88%Keefe, Bruyette & Woods
Ryan Lynch
→ $18Initiates → OutperformGet Alert
02/24/2023CCAPBuy Now
Crescent Capital BDC
$16.687.88%Oppenheimer
Mitchel Penn
$19 → $18MaintainsOutperformGet Alert
10/05/2022CCAPBuy Now
Crescent Capital BDC
$16.687.88%Raymond James
Robert Dodd
$20.5 → $18MaintainsOutperformGet Alert
08/12/2022CCAPBuy Now
Crescent Capital BDC
$16.6813.87%Oppenheimer
Mitchel Penn
$20 → $19UpgradePerform → OutperformGet Alert
08/12/2022CCAPBuy Now
Crescent Capital BDC
$16.6822.86%Raymond James
Robert Dodd
$21 → $20.5MaintainsOutperformGet Alert
05/11/2022CCAPBuy Now
Crescent Capital BDC
$16.687.88%Wells Fargo
Finian O'Shea
$18.5 → $18MaintainsOverweightGet Alert
04/25/2022CCAPBuy Now
Crescent Capital BDC
$16.6810.88%Wells Fargo
Finian O'Shea
$19.5 → $18.5MaintainsOverweightGet Alert
01/31/2022CCAPBuy Now
Crescent Capital BDC
$16.6816.87%B of A Securities
Derek Hewett
→ $19.5Initiates → BuyGet Alert
11/12/2021CCAPBuy Now
Crescent Capital BDC
$16.6828.86%Raymond James
Robert Dodd
MaintainsOutperformGet Alert
07/16/2021CCAPBuy Now
Crescent Capital BDC
$16.68OppenheimerInitiates → PerformGet Alert
Q

What is the target price for Crescent Capital BDC (CCAP)?

A

The latest price target for Crescent Capital BDC (NASDAQ: CCAP) was reported by Wells Fargo on November 13, 2023. The analyst firm set a price target for $16.00 expecting CCAP to fall to within 12 months (a possible -4.11% downside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Crescent Capital BDC (CCAP)?

A

The latest analyst rating for Crescent Capital BDC (NASDAQ: CCAP) was provided by Wells Fargo, and Crescent Capital BDC downgraded their equal-weight rating.

Q

When is the next analyst rating going to be posted or updated for Crescent Capital BDC (CCAP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Crescent Capital BDC, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Crescent Capital BDC was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.

Q

Is the Analyst Rating Crescent Capital BDC (CCAP) correct?

A

While ratings are subjective and will change, the latest Crescent Capital BDC (CCAP) rating was a downgraded with a price target of $16.50 to $16.00. The current price Crescent Capital BDC (CCAP) is trading at is $16.68, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.